Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease

被引:6
|
作者
Pantelopulos, George A. [1 ]
Abraham, Conor B. [1 ]
Straub, John E. [1 ]
机构
[1] Boston Univ, Dept Chem, Boston, MA 02215 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
amyloid precursor protein; cholesterol; cellular compartment; lipid bilayer; lipid phase; molecular dynamics; CLEAVING ENZYME 1; PRECURSOR-PROTEIN; GAMMA-SECRETASE; TRANSMEMBRANE DOMAIN; PLASMA-MEMBRANE; PHASE-BEHAVIOR; S-PALMITOYLATION; DISINTEGRIN/METALLOPROTEINASE ADAM10; CRITICAL FLUCTUATIONS; MAGNETIC-RESONANCE;
D O I
10.1146/annurev-biophys-062823-023436
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cholesterol has been conjectured to be a modulator of the amyloid cascade, the mechanism that produces the amyloid-beta (A beta) peptides implicated in the onset of Alzheimer's disease.We propose that cholesterol impacts the genesis of A beta not through direct interaction with proteins in the bilayer, but indirectly by inducing the liquid-ordered phase and accompanying liquid-liquid phase separations, which partition proteins in the amyloid cascade to different lipid domains and ultimately to different endocytotic pathways.We explore the full process of A beta genesis in the context of liquid-ordered phases induced by cholesterol, including protein partitioning into lipid domains, mechanisms of endocytosis experienced by lipid domains and secretases, and pH-controlled activation of amyloid precursor protein secretases in specific endocytotic environments. Outstanding questions on the essential role of cholesterol in the amyloid cascade are identified for future studies.
引用
收藏
页码:455 / 486
页数:32
相关论文
共 50 条
  • [21] Intracellular amyloid-β in Alzheimer's disease
    Frank M. LaFerla
    Kim N. Green
    Salvatore Oddo
    Nature Reviews Neuroscience, 2007, 8 : 499 - 509
  • [22] Autoantibodies to amyloid-β and Alzheimer's disease
    Hyman, BT
    Smith, C
    Buldyrev, I
    Whelan, C
    Brown, H
    Tang, MX
    Mayeux, R
    ANNALS OF NEUROLOGY, 2001, 49 (06) : 808 - 810
  • [23] Presenilins, amyloid-β and Alzheimer's disease
    Bruce T. Lamb
    Nature Medicine, 1997, 3 : 28 - 29
  • [24] Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling
    Hicks, David A.
    Nalivaeva, Natalia N.
    Turner, Anthony J.
    FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [25] Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
    Ehehalt, R
    Keller, P
    Haass, C
    Thiele, C
    Simons, K
    JOURNAL OF CELL BIOLOGY, 2003, 160 (01): : 113 - 123
  • [26] Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease
    Salazar, Santiago V.
    Strittmatter, Stephen M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (04) : 1143 - 1147
  • [27] Novel strategies for the fight of Alzheimer's disease targeting amyloid-β protein
    Xie, Yang
    Wang, Yan
    Jiang, Shangfei
    Xiang, Xiaohong
    Wang, Jianhua
    Ning, Linhong
    JOURNAL OF DRUG TARGETING, 2022, 30 (03) : 259 - 268
  • [28] Pathogenesis of Alzheimer's Disease: Role of Amyloid-β and Hyperphosphorylated Tau Protein
    Sajjad, Rabia
    Arif, Rawaba
    Shah, A. A.
    Manzoor, I.
    Mustafa, G.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (04) : 581 - 591
  • [29] Amyloid-β Precursor Protein Synthesis Inhibitors for Alzheimer's Disease Treatment
    Greig, Nigel H.
    Sambamurti, Kumar
    Lahiri, Debomoy K.
    Becker, Robert E.
    ANNALS OF NEUROLOGY, 2014, 76 (04) : 629 - 630
  • [30] Cholesterol and lipid rafts in amyloid β endocytosis and neurotoxicity
    de Chaves, E. I. Posse
    Mohamed, A.
    Saavedra, L.
    JOURNAL OF NEUROCHEMISTRY, 2010, 113 : 23 - 24